ADVERTISEMENTs
Vector BioMed and Kailash Cancer Hospital bring cutting edge medical care to rural India
The Gujarat hospital will begin treatment of patients with CAR-T cell therapy in 2026.
-
Staff Reporter - Thu, 26, Jun 2025
- 03:20 EDT
- 13
.jpg)
Dr. Boro Dropulić and Dr. Vikram Patel / PR Newswire
Vector BioMed, a Maryland based contract vector development and manufacturing organization (CVDMO), is partnering with Muni Seva Ashram's Kailash Cancer Hospital and Research Center (KCHRC) in Gujarat.
The partnership hopes to bring affordable CAR-T cancer treatment to underserved populations.
Having completed due diligence, site visits, and technical evaluations by KCHRC's leadership, including the Chair of Muni Seva Ashram Dr. Vikram Patel, the hospital is expected to begin treating its first patients with autologous CAR-T cell therapy in 2026, making it the first site in Gujarat and one of the first in India to deliver advanced treatments outside of a major metropolitan area.
Vector BioMed supplies medical technology and services that streamline development for hospitals and researchers, this introduces speed, consistency, and a dramatic improvement to the global standard of care for cancer treatment.
Dr. Boro Dropulić, CEO of Vector BioMed addressed the partnership and said, "We are pleased to collaborate with Muni Seva Ashram and be a part of bringing financially feasible treatments to patients who never imagined having access."
He added, "Through this partnership, we're delivering one of the world's most advanced cancer therapies to communities that have long been excluded from cutting-edge care. It's a powerful step toward making world-class care truly universal."
Dr. Patel highlighted the importance of accessibility and said, "This collaboration brings us closer to our goal of providing world-class cancer treatment to every patient who walks through our doors, regardless of their ability to pay."
He added, "Vector BioMed's knowledge and excellence in vector manufacturing and clinical support has strongly impacted our cell therapy efforts – and will soon greatly impact the lives of our patients."
"We're living our mission of immediate global access – delivering real solutions to real people – which directly supports Muni Seva Ashram's institution. Together, we're breaking economic and geographic barriers," added Dr. Dropulić. "With Muni Seva Ashram, we're proving that access to life-saving therapies should not depend on where you live or what you can afford."
ALSO READ: Community partnerships key to India’s rural healthcare system: Sri Madhusudan Sai
Related
.JPG)
.png)
.jpg)
 (1).jpg)
.jpg)
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login